XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Condensed Balance Sheets - USD ($)
$ in Millions
Mar. 30, 2024
Sep. 30, 2023
Assets    
Cash and cash equivalents $ 2,182 $ 573
Accounts receivable, net 2,358 2,476
Inventories 5,056 5,328
Other current assets 370 345
Total Current Assets 9,966 8,722
Net Property, Plant and Equipment 9,593 9,634
Goodwill 9,878 9,878
Intangible Assets, net 5,985 6,098
Other Assets 2,043 1,919
Total Assets 37,465 36,251
Liabilities and Shareholders' Equity    
Current debt 1,315 1,895
Accounts payable 2,244 2,594
Other current liabilities 2,074 2,010
Total Current Liabilities 5,633 6,499
Long-Term Debt 9,645 7,611
Deferred Income Taxes 2,292 2,308
Other Liabilities 1,672 1,578
Shareholders' Equity:    
Capital in excess of par value 4,556 4,560
Retained earnings 18,667 18,760
Accumulated other comprehensive gain (loss) (252) (260)
Treasury stock, at cost – 91 million shares at March 30, 2024 and 92 million shares at September 30, 2023 (4,927) (4,972)
Total Tyson Shareholders’ Equity 18,089 18,133
Noncontrolling Interests 134 122
Total Shareholders’ Equity 18,223 18,255
Total Liabilities and Shareholders’ Equity 37,465 36,251
Class A [Member]    
Shareholders' Equity:    
Common stock ($0.10 par value): 38 38
Class B [Member]    
Shareholders' Equity:    
Common stock ($0.10 par value): $ 7 $ 7